Jeff Swigris

1.3k total citations
18 papers, 339 citations indexed

About

Jeff Swigris is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Speech and Hearing. According to data from OpenAlex, Jeff Swigris has authored 18 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 9 papers in Physiology and 2 papers in Speech and Hearing. Recurrent topics in Jeff Swigris's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (15 papers), Respiratory and Cough-Related Research (5 papers) and Sarcoidosis and Beryllium Toxicity Research (5 papers). Jeff Swigris is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (15 papers), Respiratory and Cough-Related Research (5 papers) and Sarcoidosis and Beryllium Toxicity Research (5 papers). Jeff Swigris collaborates with scholars based in United States, Netherlands and United Kingdom. Jeff Swigris's co-authors include Marjon Elfferich, Anne‐Marie Russell, Bert Strookappe, Marjolein Drent, Elizabeth A. Fagan, Lisa Lancaster, Ulrich Costabel, Eduard Gorina, Carlo Albera and Marilyn K. Glassberg and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, CHEST Journal and European Respiratory Journal.

In The Last Decade

Jeff Swigris

16 papers receiving 332 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeff Swigris United States 7 306 181 43 27 25 18 339
Svenja Ehlers-Tenenbaum Germany 5 377 1.2× 168 0.9× 49 1.1× 42 1.6× 23 0.9× 8 386
Öznur Abadoğlu Türkiye 13 146 0.5× 190 1.0× 56 1.3× 20 0.7× 15 0.6× 30 365
Kathryn Barker Australia 7 217 0.7× 55 0.3× 10 0.2× 42 1.6× 28 1.1× 16 294
Ogugua Ndili United States 10 187 0.6× 195 1.1× 13 0.3× 34 1.3× 21 0.8× 32 248
R.M. Wirnsberger Netherlands 7 334 1.1× 345 1.9× 97 2.3× 17 0.6× 70 2.8× 9 420
Pauline Bianchi United States 5 161 0.5× 62 0.3× 9 0.2× 23 0.9× 7 0.3× 10 200
Tamara Alonso Spain 7 83 0.3× 56 0.3× 53 1.2× 29 1.1× 8 0.3× 30 208
Morgane Didier France 6 131 0.4× 84 0.5× 5 0.1× 20 0.7× 42 1.7× 22 254
Murat Çapanoğlu Türkiye 12 132 0.4× 168 0.9× 33 0.8× 12 0.4× 5 0.2× 23 382
Krzysztof Kuziemski Poland 9 123 0.4× 67 0.4× 12 0.3× 29 1.1× 8 0.3× 50 238

Countries citing papers authored by Jeff Swigris

Since Specialization
Citations

This map shows the geographic impact of Jeff Swigris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeff Swigris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeff Swigris more than expected).

Fields of papers citing papers by Jeff Swigris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeff Swigris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeff Swigris. The network helps show where Jeff Swigris may publish in the future.

Co-authorship network of co-authors of Jeff Swigris

This figure shows the co-authorship network connecting the top 25 collaborators of Jeff Swigris. A scholar is included among the top collaborators of Jeff Swigris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeff Swigris. Jeff Swigris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Mudaranthakam, Dinesh Pal, Susan Mathai, Ayodeji Adegunsoye, et al.. (2025). Pragmatic Comparative Effectiveness Trials in Rheumatoid Arthritis-Associated Interstitial Lung Disease. PubMed. 3(2). 100159–100159.
2.
Ho, Lawrence, Nishant Gupta, Joel Moss, et al.. (2024). Unsupervised Exercise in Interstitial Lung Disease. CHEST Journal. 166(5). 1108–1123. 2 indexed citations
3.
Wijsenbeek, Marlies, María Molina‐Molina, Olivier Chassany, et al.. (2022). Developing a conceptual model of symptoms and impacts in progressive fibrosing interstitial lung disease to evaluate patient-reported outcome measures. ERJ Open Research. 8(2). 681–2021. 10 indexed citations
4.
Swigris, Jeff, et al.. (2022). Determining and reporting minimal important change for patient-reported outcome instruments in pulmonary medicine. European Respiratory Journal. 60(4). 2200717–2200717. 4 indexed citations
5.
Guler, Sabina A., Kathleen O. Lindell, Jeff Swigris, & Christopher J. Ryerson. (2021). What Is Idiopathic Pulmonary Fibrosis? IPF Part 1. American Journal of Respiratory and Critical Care Medicine. 203(2). P5–P6. 6 indexed citations
6.
Guler, Sabina A., Kathleen O. Lindell, Jeff Swigris, & Christopher J. Ryerson. (2021). Nondrug Treatments for Idiopathic Pulmonary Fibrosis: IPF Part 3. American Journal of Respiratory and Critical Care Medicine. 203(4). P10–P11.
7.
Guler, Sabina A., Kathleen O. Lindell, Jeff Swigris, & Christopher J. Ryerson. (2021). Medications for Idiopathic Pulmonary Fibrosis: IPF Part 2. American Journal of Respiratory and Critical Care Medicine. 203(3). P7–P8. 2 indexed citations
8.
9.
Natalini, Jake G., Jeff Swigris, Julie Morisset, et al.. (2017). Understanding the determinants of health-related quality of life in rheumatoid arthritis-associated interstitial lung disease. Respiratory Medicine. 127. 1–6. 29 indexed citations
10.
Albera, Carlo, Ulrich Costabel, Elizabeth A. Fagan, et al.. (2016). Efficacy of pirfenidone in patients with idiopathic pulmonary fibrosis with more preserved lung function. European Respiratory Journal. 48(3). 843–851. 113 indexed citations
11.
Russell, Anne‐Marie, et al.. (2015). The need for patient-centred clinical research in idiopathic pulmonary fibrosis. BMC Medicine. 13(1). 240–240. 23 indexed citations
12.
Strookappe, Bert, et al.. (2015). Benefits of Physical Training in Sarcoidosis. Lung. 193(5). 701–708. 42 indexed citations
13.
Strookappe, Bert, et al.. (2015). Benefits of physical training in patients with sarcoidosis. PA831–PA831. 2 indexed citations
14.
Strookappe, Bert, et al.. (2015). Benefits of physical training in patients with idiopathic or end-stage sarcoidosis-related pulmonary fibrosis: a pilot study.. PubMed. 32(1). 43–52. 30 indexed citations
15.
16.
Yorke, Janelle, Anne‐Marie Russell, Jeff Swigris, et al.. (2011). Assessment of Dyspnea in Asthma: Validation of the Dyspnea-12. Journal of Asthma. 48(6). 602–608. 65 indexed citations
17.
Sung, Arthur, Jeff Swigris, Anthony Saleh, & Suhail Raoof. (2007). High-resolution chest tomography in idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia: utility and challenges. Current Opinion in Pulmonary Medicine. 13(5). 451–457. 4 indexed citations
18.
Swigris, Jeff, et al.. (2006). LONGITUDINAL TRENDS IN DYSPNEA IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF): THE BUILD 1 STUDY. CHEST Journal. 130(4). 282S–282S. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Svenja Ehlers-Tenenbaum Breakdown of academic impact, for papers by Öznur Abadoğlu Breakdown of academic impact, for papers by Kathryn Barker Breakdown of academic impact, for papers by Ogugua Ndili Breakdown of academic impact, for papers by R.M. Wirnsberger Breakdown of academic impact, for papers by Pauline Bianchi Breakdown of academic impact, for papers by Tamara Alonso Breakdown of academic impact, for papers by Morgane Didier Breakdown of academic impact, for papers by Murat Çapanoğlu Breakdown of academic impact, for papers by Krzysztof Kuziemski
Rankless by CCL
2026